Arcus Biosciences Inc (RCUS)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 462,000 520,000 566,000 600,000 657,000 699,000 747,000 797,000 842,000 542,607 604,555 664,790 502,000 544,417 428,710 140,638 164,000 177,227 196,646 221,567
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $462,000K)
= 0.00

The debt-to-capital ratio of Arcus Biosciences Inc has consistently been reported as 0.00 throughout the past eight quarters. This indicates that the company has not utilized any debt financing in relation to its capital structure during this period. A debt-to-capital ratio of 0.00 suggests that the company relies solely on equity financing for its operations and growth initiatives. It may signify a conservative financial strategy aimed at minimizing financial risk and interest expenses. However, it is essential to consider other factors, such as the company's overall financial health, liquidity position, and future growth prospects, to gain a comprehensive understanding of its financial strength and stability.


Peer comparison

Dec 31, 2023